Amla (Indian Gooseberry): Benefits, Forms, Dosing, and Side Effects

Overview

Amla (Emblica officinalis), also known as amalaki or Indian gooseberry, is one of the most widely used ingredients in traditional Ayurvedic medicine. The fruit has been used for thousands of years across the Indian subcontinent for a broad range of health conditions, and in recent decades has attracted scientific interest for its potential effects on blood sugar control, blood lipid levels, cardiovascular health, and digestive function [1][2].

The amla fruit is primarily composed of carbohydrates, roughly half of which is dietary fiber. Its most notable nutritional feature is an exceptionally high vitamin C content — approximately 600 to 700 mg per fresh fruit, making it one of the richest natural sources of ascorbic acid [1][3]. Beyond vitamin C, amla contains a diverse array of phenolic compounds including tannins (both hydrolyzable and condensed), flavonoids, gallic acid, ellagic acid, and the phenolic ester beta-glucogallin [1]. These compounds are responsible for the fruit's characteristic tartness and astringency, and are believed to contribute to its biological activity.

Beta-glucogallin has attracted particular attention for its potential antidiabetic effects. Laboratory research suggests it may inhibit enzymes involved in glucose metabolism, though the clinical evidence remains preliminary [1]. The hydrolyzable tannins in amla, particularly low-molecular-weight tannins, have been investigated for antiplatelet and anti-inflammatory properties [1][4].

Despite centuries of traditional use and a growing number of clinical studies, most of the human evidence for amla remains preliminary. Studies tend to be small (16 to 124 participants), short-term (4 to 12 weeks), and many lack placebo controls [1]. Larger, longer-term randomized controlled trials are needed to confirm the potential health benefits suggested by the existing research.

Table of Contents

• Overview
• Forms and Bioavailability
• Evidence for Health Benefits
• Recommended Dosing
• Safety and Side Effects
• Drug Interactions
• Dietary Sources
• References

Forms and Bioavailability

Available Forms

Amla is sold in a variety of forms for both culinary and supplemental use:

• Fresh fruit — whole amla fruit, available in specialty markets. Contains the full complement of vitamin C, fiber, and phenolic compounds.
• Frozen fruit — preserves more of the vitamin C and phenolic content than dried or processed forms.
• Fruit juice — concentrated liquid form. Often used in Ayurvedic preparations. Vitamin C content varies widely by processing method.
• Fruit syrup — sweetened liquid preparation. Used in some clinical trials at doses of 10 mL three times daily [5].
• Fruit powder — dried and ground whole fruit. Common supplement form. Retains fiber content. Doses of 1 to 3 grams per day have been used in clinical studies [1][6].
• Fruit extract — concentrated form, typically standardized to specific levels of phenolic compounds. May be standardized to polyphenols, tannins, gallic acid equivalents, beta-glucogallin, or triterpenoids. Doses of 500 mg to 1,000 mg per day are common in clinical trials [1][4][7][8].

Standardization

The lack of a unified standardization approach is a significant issue with amla supplements. Different products are standardized to different marker compounds:

• Phenols or polyphenols — broad measure of total phenolic content. One clinical trial used an extract standardized to approximately 175 mg polyphenols per 500 mg dose [7].
• Tannins / gallic acid equivalents — gallic acid is a naturally occurring phenolic compound used as a reference standard to quantify total tannin content. Some products report their polyphenol content as "gallic acid equivalents" [1].
• Beta-glucogallin — the Saberry extract (by Sabinsa) is standardized to 10% beta-glucogallin and hydrolyzable tannins, and was used in the largest diabetes trial [8].
• Low-molecular-weight hydrolyzable tannins — the CAPROS extract (by Natreon) is standardized to 60% low-molecular-weight hydrolyzable tannins, and was used in cardiovascular studies [4].
• Triterpenoids — some extracts also report triterpenoid content. One cholesterol-lowering trial used an extract with approximately 40 mg triterpenoids per 500 mg dose [7].

Because different extracts contain different concentrations of active compounds, results from one standardized extract may not apply to another. Consumers should note which extract was used in clinical trials and seek products with matching standardization when possible.

Vitamin C Content in Supplements

An important caveat: while fresh amla fruit is exceptionally rich in vitamin C (600–700 mg per fruit), the vitamin C content of amla supplements can be very low — often less than 10 mg per serving [1]. Most amla supplements do not even list their vitamin C content on the label. This is a significant discrepancy, and consumers seeking amla primarily for its vitamin C content should verify the amount on the product label rather than assuming the supplement retains the vitamin C levels found in fresh fruit.

Storage

Due to the possibility of decomposition of bioactive compounds, which is accelerated by moisture and heat, amla powder should be stored in a cool, dry place. Refrigeration is not necessary [1].

Evidence for Health Benefits

Although amla has been promoted for numerous conditions, many of these uses have not been evaluated in clinical studies. Among the uses that have been investigated in humans, most studies have been small and preliminary [1]. The following sections detail the available human evidence organized by condition.

Blood Sugar and Diabetes

Amla has been traditionally used in Ayurvedic medicine for type 2 diabetes, and laboratory research suggests that beta-glucogallin from amla may have antidiabetic effects through enzyme inhibition pathways [1]. Three clinical studies have examined the effects of amla on blood sugar control in humans.

Amla fruit powder in type 2 diabetes (uncontrolled): A small study in Pakistan enrolled 16 men and women with non-insulin-dependent type 2 diabetes. Participants took 1 to 3 grams of powdered amla fruit daily. After approximately 2 to 3 weeks, both pre-meal and post-meal blood sugar levels appeared to decrease. However, the study did not include a placebo group, which limits the ability to attribute the observed improvements to amla rather than natural variation, dietary changes, or placebo effect (Akhtar, Int J Food Sci Nutr, 2011) [6].

Amla fruit extract versus metformin (active-controlled): The largest and most informative study to date was conducted in India among 124 men and women (average age 47) who had been recently diagnosed with type 2 diabetes but were not yet taking diabetes medication. Participants were randomized to receive either 2 grams per day of amla fruit extract (Saberry by Sabinsa, standardized to 10% beta-glucogallin and hydrolyzable tannins) or 500 mg per day of metformin for 3 months. Key findings [8]:

• Fasting blood sugar decreased by 6 mg/dL more in the amla group than in the metformin group
• Post-meal blood sugar decreased by 13 mg/dL more in the amla group
• HbA1c decreased by 0.3% more in the amla group than in the metformin group

These results suggest that amla extract may have comparable or slightly greater effects on blood sugar control than a low dose of metformin in newly diagnosed, untreated type 2 diabetes. However, several important limitations apply: the study was funded and conducted by Sabinsa (the manufacturer of the Saberry extract), the metformin dose (500 mg/day) was at the low end of the therapeutic range (typically 1,000–2,000 mg/day), and the study lacked a true placebo group [8].

Clinical significance: More research is needed to determine whether there is a true and durable benefit, which compounds in amla are responsible for the blood sugar effects and at what optimal dose, and critically, whether amla is safe to take alongside diabetes medications. The risk of hypoglycemia when combining amla with diabetes drugs has not been adequately studied [1].

Heart Health and Cholesterol

Amla contains flavonoids that have been shown in laboratory studies to block the activity of HMG-CoA reductase, the enzyme involved in cholesterol production — the same enzyme targeted by statin medications [1]. Several small clinical studies have investigated amla's effects on blood lipid levels and cardiovascular risk markers.

Amla versus simvastatin (active-controlled): A small study in India among 60 people with high cholesterol compared two treatment groups: one receiving 20 mg of simvastatin daily and the other receiving 500 mg of amla fruit powder as capsules once daily at bedtime for 6 weeks. Findings [9]:

• Amla and simvastatin showed similar effects on total cholesterol, LDL ("bad") cholesterol, and HDL ("good") cholesterol
• Simvastatin produced greater reductions in very low-density lipoprotein (VLDL) cholesterol and triglycerides than amla
• Among 28 participants in the amla group and 10 in the simvastatin group who also had high blood pressure at baseline, 21 of those taking amla (75%) and 6 of those taking simvastatin (60%) showed reductions in systolic and/or diastolic blood pressure after 6 weeks
• Whether the blood pressure difference between groups was statistically significant was not reported

This study lacked a placebo group, used a relatively low simvastatin dose (20 mg), and was small, so results should be interpreted cautiously (Gopa, Indian J Pharmacol, 2012) [9].

Amla extract for dyslipidemia (placebo-controlled): A higher-quality study among 98 people with abnormal blood lipid levels tested 500 mg of amla extract (standardized to approximately 175 mg polyphenols and 40 mg triterpenoids) taken daily for 12 weeks compared to placebo. Results [7]:

• Total cholesterol decreased by 54.67 mg/dL from baseline in the amla group
• Triglycerides decreased by 89.17 mg/dL from baseline
• LDL cholesterol decreased by 28.43 mg/dL from baseline
• VLDL cholesterol decreased by 17.52 mg/dL from baseline
• All reductions were statistically significant compared to the placebo group
• The atherogenic index of plasma (AIP), a measure used to predict the risk of excess plaque buildup in arteries, showed a 39% reduction from baseline in the amla group, and this reduction was significant compared to placebo

This is the strongest clinical evidence to date for amla's lipid-lowering effects, though the study was still relatively small and of moderate duration (Upadya, BMC Complement Altern Med, 2019) [7].

Amla for cardiovascular markers in overweight/obese individuals (uncontrolled): A study in Ohio enrolled overweight or obese individuals who took 500 mg of amla extract (CAPROS by Natreon, standardized to 60% low-molecular-weight hydrolyzable tannins) twice daily (1,000 mg total/day) for 12 weeks. Findings [4]:

• HDL ("good") cholesterol increased
• High-sensitivity C-reactive protein (hs-CRP), a marker of cardiovascular disease risk, decreased
• Total cholesterol and triglyceride levels did not significantly change compared to baseline
• Platelet aggregation (clumping) induced by collagen was reduced, suggesting an antiplatelet effect that could lower blood clot risk

The lack of a control group in this study limits the significance of these findings, as improvements in cardiovascular markers could have resulted from lifestyle changes, regression to the mean, or other factors unrelated to amla supplementation (Khanna, J Med Food, 2015) [4].

Blood Pressure

Evidence for amla's effect on blood pressure is limited and comes primarily from subgroup analyses within the cholesterol studies described above.

In the amla versus simvastatin study, 75% of hypertensive participants in the amla group (21 of 28) showed reductions in systolic and/or diastolic blood pressure after 6 weeks of 500 mg amla fruit powder daily, compared to 60% in the simvastatin group (6 of 10). However, it was not reported whether this difference reached statistical significance [9].

No standalone randomized controlled trial has evaluated amla specifically for blood pressure reduction as a primary endpoint. Given the small numbers and post-hoc nature of the blood pressure observations, no firm conclusions can be drawn about amla's antihypertensive effects.

Digestive Health (GERD)

Amla for gastric ulcer healing (animal study): Amla was shown in an animal study to improve the healing of gastric and duodenal ulcers by reducing gastric acid secretion (Al-Rehaily, Phytomedicine, 2002) [10].

Amla for gastroesophageal reflux disease (placebo-controlled): A clinical study enrolled 68 people with a form of gastroesophageal reflux disease (GERD) that tends to have a lower response to proton-pump inhibitor (PPI) therapy — specifically, functional heartburn and non-erosive reflux disease. Participants took two 500 mg tablets of amla fruit powder twice daily after meals (total daily dose of 2,000 mg) or placebo for 4 weeks. Results [11]:

• Self-reported frequency of regurgitation was reduced in the amla group compared to placebo
• Self-reported severity of regurgitation was reduced in the amla group compared to placebo
• Self-reported frequency and severity of heartburn were reduced in the amla group compared to placebo

This was a relatively small study and the outcomes were based on self-report rather than objective measures such as pH monitoring. Larger, longer-term studies are needed to confirm this effect (Varnosfaderani, J Integr Med, 2018) [11].

Immunity and Common Cold

Amla fruit juice has been promoted as an immune booster to help prevent and treat the common cold or flu. The rationale is based primarily on amla's high vitamin C content — approximately 600 to 700 mg per fresh fruit (Goraya, J Food Sci Technol, 2015) [3]. Evidence from other sources shows that taking vitamin C prior to the onset of a cold may help reduce the duration and severity of cold symptoms.

However, no clinical studies have specifically evaluated the effects of amla on cold or flu risk [1]. Furthermore, the vitamin C content in amla supplements (as opposed to fresh fruit) is often very low — typically less than 10 mg per serving — and most supplements do not disclose the amount of vitamin C they provide [1]. Without clinical evidence and with uncertain vitamin C delivery in supplement form, the immune-boosting claims for amla supplements remain unsubstantiated.

Hair Growth

It has been speculated that amla might help strengthen hair follicles by boosting vitamin C levels, as well as promote hair growth through anti-inflammatory and exfoliating properties (Lanjewar, J Drug Deliv Therapeut, 2020) [12].

Amla syrup for female hair loss (placebo-controlled): A clinical trial enrolled 52 women in Iran with female androgenetic alopecia, a common cause of hair loss in women. Participants consumed 10 mL (approximately 2 teaspoons) of amla syrup standardized to 306.95 mg of gallic acid per milliliter, taken three times daily for 12 weeks, compared to a placebo syrup. Findings [5]:

• Average hair count did not significantly improve in the amla group compared to placebo
• Mean hair thickness did not significantly improve in the amla group compared to placebo
• Those in the amla group showed a slightly higher percentage of hair in the anagen (growing) phase after 12 weeks
• Those in the amla group showed a slightly lower percentage of hair in the telogen (resting) phase after 12 weeks
• These hair cycle phase differences were modest and the study was small

Overall, amla supplementation did not demonstrate clinically meaningful improvements in hair count or thickness, though it may have a marginal effect on hair cycle dynamics (Akhbari, J Ethnopharmacol, 2024) [5].

Liver and Kidney Function

Amla has shown benefit in animal research for improving liver function and kidney health, but clinical studies supporting these benefits in humans are lacking [1]. No human trials have evaluated amla's effects on liver enzymes, liver fibrosis markers, or kidney function parameters as primary outcomes.

Cognitive Function and Dementia

Amla has been shown to possess anticholinesterase activity in animal research, suggesting it may have benefit in the management of dementia or Alzheimer's disease (Golechha, J Environ Biol, 2012) [13]. Anticholinesterase inhibitors (such as donepezil and rivastigmine) are the mainstay of symptomatic treatment for Alzheimer's disease, so a natural compound with similar activity is of theoretical interest.

However, no human studies have evaluated the effects of amla on cognitive function, memory, or dementia risk. The animal findings, while mechanistically interesting, cannot be extrapolated to clinical recommendations.

Eye Health (Macular Degeneration and Cataract)

Amla has been promoted for preventing age-related macular degeneration and cataracts, likely based on its antioxidant properties and vitamin C content. However, no clinical studies have assessed the effects of amla on these eye conditions in humans [1].

Skin Aging

Amla has been promoted for improving the appearance of aging skin, again likely based on its antioxidant and vitamin C content. Vitamin C is known to play a role in collagen synthesis and photoprotection. However, no clinical studies have assessed the effects of amla supplementation on skin aging parameters in humans [1].

Cancer Prevention

Amla has been promoted for cancer prevention, and some in vitro and animal studies have suggested antiproliferative effects. However, no clinical studies have assessed the effects of amla on cancer incidence, cancer mortality, or cancer biomarkers in humans [1].

Diuretic Effect

Amla fruit has been traditionally used in Indian medicine for its diuretic effect — increasing urine output (Talreja, WJPPS, 2019; Grover, J Oral Res Rev, 2015) [14][15]. Theoretically, consuming amla fruit or supplements may increase the volume and/or frequency of urination. However, this side effect does not appear to have been reported in the clinical trials summarized above, and the mechanism of action of such an effect is not well characterized [1].

Recommended Dosing

There is no established recommended daily intake or standardized dosing protocol for amla. Dosing in clinical trials has varied substantially depending on the form used (whole fruit powder versus concentrated extract) and the health condition being studied.

Dosing by Form and Indication

Form	Dose	Duration	Condition Studied	Study
Amla fruit powder	1–3 g/day	2–3 weeks	Type 2 diabetes (blood sugar)	Akhtar 2011 [6]
Amla fruit extract (Saberry, 10% beta-glucogallin)	2 g/day	3 months	Type 2 diabetes (blood sugar, HbA1c)	Majeed 2023 [8]
Amla fruit powder	500 mg/day (once at bedtime)	6 weeks	High cholesterol	Gopa 2012 [9]
Amla fruit extract (standardized polyphenols)	500 mg/day	12 weeks	Dyslipidemia (cholesterol, triglycerides)	Upadya 2019 [7]
Amla extract (CAPROS, 60% tannins)	500 mg twice daily (1,000 mg/day)	12 weeks	Cardiovascular markers (overweight/obese)	Khanna 2015 [4]
Amla fruit powder	2,000 mg/day (500 mg × 2, twice daily)	4 weeks	GERD (heartburn, regurgitation)	Varnosfaderani 2018 [11]
Amla syrup (306.95 mg gallic acid/mL)	10 mL three times daily	12 weeks	Female hair loss	Akhbari 2024 [5]

General Guidance

• For blood sugar control: 1 to 3 grams daily of amla fruit powder, or 2 grams daily of a standardized fruit extract (10% beta-glucogallin) [1][6][8].
• For cholesterol lowering: 500 mg daily of amla fruit extract or amla fruit powder [1][7][9].
• For GERD / digestive symptoms: 2,000 mg daily of amla fruit powder, divided into two doses taken after meals [11].
• Timing: It is not clear whether amla is best taken at any particular time of day or with or without food [1].
• Powder preparation: Amla powders are meant to be mixed with water or another beverage, such as juice, or blended into a smoothie [1].

Important Caveats

These dosing suggestions are based on small, short-term studies, many with significant methodological limitations. There are no long-term safety or efficacy studies to guide chronic use. The optimal dose, form, and standardization of amla for any given health condition remain uncertain. Anyone considering amla supplementation for a specific health condition should discuss this with their healthcare provider, particularly if taking medications for diabetes or blood thinning.

Safety and Side Effects

General Safety

Amla fruit is considered safe to consume in normal dietary amounts as a food [1]. It has been consumed as a food and traditional remedy in India for centuries without reports of widespread toxicity. However, taking amla in concentrated supplemental doses may have side effects and interactions that are not apparent from dietary consumption.

Known and Potential Side Effects

Blood sugar lowering: Amla may lower blood sugar levels. While this is a potential benefit for people with diabetes or prediabetes, it creates a risk of hypoglycemia (dangerously low blood sugar) in people who are already taking diabetes medications such as metformin, sulfonylureas, or insulin. The interaction between amla and diabetes drugs has not been adequately studied. Anyone taking diabetes medications should consult their doctor before taking amla, as dose adjustments to diabetes medications might be necessary [1].

Antiplatelet effects and bleeding risk: Amla may reduce blood clotting through its antiplatelet effects. The CAPROS study demonstrated that amla extract reduced collagen-induced platelet aggregation in overweight/obese individuals [4]. This antiplatelet effect means amla may increase the risk of bleeding, particularly in people with bleeding disorders or those taking blood-thinning medications such as warfarin, aspirin, clopidogrel, or direct oral anticoagulants. Anyone with a bleeding disorder or taking anticoagulant or antiplatelet medications should consult their doctor before taking amla [1].

Anticholinesterase activity: Amla has demonstrated anticholinesterase activity in animal research [13]. This means it could theoretically interfere with anticholinergic drugs such as atropine (Atropen) and benztropine (Cogentin), which are used to treat conditions ranging from bradycardia to Parkinson's disease symptoms. The clinical significance of this interaction in humans is not established, but caution is warranted [1].

Diuretic effect: Amla has traditionally been used as a diuretic. Theoretically, supplementation may increase the volume and/or frequency of urination, though this has not been reported in the clinical trials reviewed above [1][14][15].

Gastrointestinal effects: Due to its high tannin content and astringency, amla may cause GI discomfort in some individuals, particularly at higher doses. However, significant GI side effects were not prominently reported in the clinical trials reviewed.

Side Effects Not Reported in Clinical Trials

The clinical trials on amla have generally been small (16–124 participants) and short (2–12 weeks), which means that rare or long-term side effects may not have been detected. The safety profile of chronic amla supplementation beyond 12 weeks is largely unknown.

Drug Interactions

Medications That May Interact with Amla

Drug Class	Examples	Nature of Interaction	Clinical Implication
Diabetes medications	Metformin, sulfonylureas, insulin, SGLT2 inhibitors	Additive blood sugar lowering	Risk of hypoglycemia. Monitor blood sugar closely; dose adjustment may be needed [1][8]
Anticoagulants	Warfarin (Coumadin), heparin, enoxaparin	Additive antiplatelet/anticoagulant effect	Increased bleeding risk. Consult doctor before use [1][4]
Antiplatelet drugs	Aspirin, clopidogrel (Plavix)	Additive antiplatelet effect	Increased bleeding risk. Consult doctor before use [1][4]
Anticholinergic drugs	Atropine (Atropen), benztropine (Cogentin)	Amla's anticholinesterase activity may oppose drug effects	May reduce effectiveness of anticholinergic medications [1][13]
Statins	Simvastatin, atorvastatin, rosuvastatin	Possible additive cholesterol-lowering effect	May be beneficial but requires monitoring. One study compared amla directly to simvastatin [9]
Diuretics	Furosemide, hydrochlorothiazide	Possible additive diuretic effect	Theoretical; monitor hydration and electrolytes [14][15]

Surgical Considerations

Due to its antiplatelet effects, amla supplementation should be discontinued at least 2 weeks before scheduled surgery to reduce the risk of excessive bleeding. Discuss with your surgeon and anesthesiologist [1][4].

Dietary Sources

Amla is primarily consumed as a food in South Asia, where it is used in a variety of culinary preparations.

Fresh Amla Fruit

Fresh amla fruit is the richest dietary source of amla's bioactive compounds. Each fruit provides approximately 600–700 mg of vitamin C, along with the full spectrum of tannins, flavonoids, gallic acid, ellagic acid, and beta-glucogallin [3]. Fresh amla has a distinctive sour, bitter, and astringent taste.

Common Culinary Preparations

• Amla pickle (achar) — fresh amla preserved in oil, spices, and salt. A staple condiment in Indian cuisine.
• Amla candy (murabba) — amla fruit preserved in sugar syrup. Sweet and tangy.
• Amla juice — fresh-pressed or reconstituted from powder. Often mixed with other fruit juices to improve palatability.
• Amla chutney — ground fresh amla with spices, herbs, and sometimes coconut.
• Dried amla — dehydrated slices or pieces, sometimes salted or spiced. Shelf-stable snack.
• Chyawanprash — a traditional Ayurvedic jam-like preparation where amla is the primary ingredient, combined with ghee, honey, sesame oil, and numerous herbs and spices.

Nutritional Profile of Fresh Amla Fruit (per 100g)

Nutrient	Amount
Calories	~44 kcal
Carbohydrates	~10 g
Fiber	~4.3 g
Vitamin C	~600–700 mg
Protein	~0.9 g
Fat	~0.6 g

Note: Nutritional values vary by variety, growing conditions, and ripeness.

Availability

Fresh amla fruit is seasonal (typically harvested October through February in India) and is available in Indian grocery stores and specialty markets in countries with significant South Asian populations. Frozen amla and amla juice are more widely available year-round. Amla powder is the most accessible form globally, available in health food stores and online retailers.

References

1. ConsumerLab. "Amla Supplements Review." Accessed 2026. https://www.consumerlab.com/reviews/amla-review-comparisons/amla/

2. Traditional Ayurvedic usage references cited in ConsumerLab and clinical literature.

3. Goraya RK, Bajwa U. "Enhancing the functional properties and nutritional quality of ice cream with processed amla (Indian gooseberry)." J Food Sci Technol. 2015;52(12):7861-7871.

4. Khanna S, Das A, Spieldenner J, et al. "Supplementation of a Standardized Extract from Phyllanthus emblica Improves Cardiovascular Risk Factors and Platelet Aggregation in Overweight/Class-1 Obese Adults." J Med Food. 2015;18(4):415-420. https://doi.org/10.1089/jmf.2014.0178

5. Akhbari M, et al. "Effect of amla (Phyllanthus emblica) syrup on female androgenetic alopecia: A randomized, double-blind, placebo-controlled trial." J Ethnopharmacol. 2024. https://doi.org/10.1016/j.jep.2024.117888

6. Akhtar MS, Ramzan A, Ali A, Ahmad M. "Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients." Int J Food Sci Nutr. 2011;62(6):609-616. https://doi.org/10.3109/09637486.2011.560565

7. Upadya H, Prabhu S, Prasad A, et al. "A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia." BMC Complement Altern Med. 2019;19(1):27. https://doi.org/10.1186/s12906-019-2430-y

8. Majeed M, Majeed S, Nagabhushanam K, et al. "A randomized, double-blind, active controlled study to evaluate the efficacy of Saberry (standardized amla extract) on glycemic markers in newly diagnosed type 2 diabetes patients." Food Funct. 2023;14(9):4091-4102. https://doi.org/10.1039/D2FO03183A

9. Gopa B, Bhatt J, Hemavathi KG. "A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin." Indian J Pharmacol. 2012;44(2):238-242. https://doi.org/10.4103/0253-7613.93857

10. Al-Rehaily AJ, Al-Howiriny TA, Al-Sohaibani MO, Rafatullah S. "Gastroprotective effects of 'Amla' Emblica officinalis on in vivo test models in rats." Phytomedicine. 2002;9(6):515-522. https://doi.org/10.1078/09447110260573146

11. Varnosfaderani SM, Hashem-Dabaghian F, Amin G, et al. "Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial." J Integr Med. 2018;16(2):126-131. https://doi.org/10.1016/j.joim.2018.02.008

12. Lanjewar A, Maurya PK. "Comprehensive Review: Indian Gooseberry (Amla) for Hair and Skin." J Drug Deliv Therapeut. 2020.

13. Golechha M, Bhatia J, Arya DS. "Studies on effects of Emblica officinalis (Amla) on oxidative stress and cholinergic function in scopolamine induced amnesia in mice." J Environ Biol. 2012;33(1):95-100.

14. Talreja D, Borde S, Shah R. "A review on pharmaceutical and pharmacological aspects of Emblica officinalis." World J Pharm Pharm Sci (WJPPS). 2019.

15. Grover IS, Bala S. "Amla (Emblica officinalis Gaertn.) — A wonder fruit." J Oral Res Rev. 2015;7(2):77.